Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Esophageal Cancer”

159 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 159 results

Testing effectiveness (Phase 2)Study completedNCT00072033
What this trial is testing

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
Swiss Cancer Institute 66
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Early research (Phase 1)Looking for participantsNCT06225921
What this trial is testing

Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas

Who this might be right for
Esophageal Squamous Cell Carcinoma
West China Hospital 6
Early research (Phase 1)Looking for participantsNCT07059299
What this trial is testing

A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma

Who this might be right for
Esophagogastric Junction AdenocarcinomaGastric AdenocarcinomaEsophageal Adenocarcinoma+2 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 18
Testing effectiveness (Phase 2)Study completedNCT02120911
What this trial is testing

Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal Carcinoma

Who this might be right for
Esophageal Carcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 40
Testing effectiveness (Phase 2)Looking for participantsNCT06272214
What this trial is testing

Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy

Who this might be right for
Adjuvant Radiotherapy
Zhejiang Cancer Hospital 146
Testing effectiveness (Phase 2)Study completedNCT06015035
What this trial is testing

Sintilimab and Anlotinib Combined With Chemotherapy in Neoadjuvant Treatment of Resectable Esophageal Cancer

Who this might be right for
Sintilimab and Anlotinib in Combination With Chemotherapy
Tang-Du Hospital 17
Testing effectiveness (Phase 2)Looking for participantsNCT06403878
What this trial is testing

Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
Sichuan University 68
Testing effectiveness (Phase 2)Study completedNCT04548440
What this trial is testing

Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC Patients

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06576973
What this trial is testing

Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Treatment
Second Affiliated Hospital, School of Medicine, Zhejiang University 35
Not applicableLooking for participantsNCT05443841
What this trial is testing

Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)

Who this might be right for
Esophageal Cancer
Fudan University 385
Not applicableStudy completedNCT01295086
What this trial is testing

Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer

Who this might be right for
Adenocarcinoma
Odense University Hospital 27
Testing effectiveness (Phase 2)UnknownNCT05007145
What this trial is testing

PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal NeoplasmsEsophageal Squamous Cell Carcinoma
Fujian Cancer Hospital 92
Large-scale testing (Phase 3)Not Yet RecruitingNCT06952621
What this trial is testing

Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Tang-Du Hospital 390
Testing effectiveness (Phase 2)Study completedNCT03087864
What this trial is testing

PDL-1 Targeting in Resectable Oesophageal Cancer

Who this might be right for
Esophageal Cancer, Stage IIEsophageal Cancer Stage III
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 40
Large-scale testing (Phase 3)Study completedNCT00160875
What this trial is testing

Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
University Health Network, Toronto 54
Testing effectiveness (Phase 2)UnknownNCT05552651
What this trial is testing

Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tao Jiang 40
Testing effectiveness (Phase 2)Looking for participantsNCT06123338
What this trial is testing

Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Who this might be right for
Esophageal CancerGastric AdenocarcinomaHER2 Gene Mutation
Memorial Sloan Kettering Cancer Center 49
Testing effectiveness (Phase 2)Study completedNCT00021320
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Fox Chase Cancer Center 21
Large-scale testing (Phase 3)UnknownNCT00041262
What this trial is testing

Combination Chemotherapy in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Medical Research Council 1,300
Load More Results